PFE · News · 20260903N
Revenue Performance and Mix
PFIZER INC · 2026-09-03 · Importance 41 · Surprise 32 · In source text
Pfizer reported second-quarter 2026 revenue of $15.03 billion, exceeding the Zacks consensus estimate. Non-COVID revenue growth and sales from newly launched and acquired products drove the quarterly beat. Core-business revenue declined 2% as COVID-19 product demand weakened and patent expirations pressured sales. Pfizer’s 2026 revenue guidance was increased, but the company still expects full-year revenue to decline from 2025 levels.
Key facts
- Pfizer reported adjusted EPS of 77 cents and revenues of $15.03 billion for Q2 2026. source
- Pfizer announced an increased revenue guidance for 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | unclear | realized | — | Pfizer reported adjusted EPS of 77 cents and revenues of $15.03 billion for Q2 2026. |
| net_income | unclear | realized | — | Pfizer reported adjusted EPS of 77 cents and revenues of $15.03 billion for Q2 2026. |
| revenue | positive | probable | — | Pfizer announced an increased revenue guidance for 2026. |